I don't think Capital injections make any difference.Revenue and FFP are irrelevant.
We can't spend more than circa £125m net in any financial year or we forfeit the terms of the stadium loans and get hit with interest rate hikes.
The current spending will be offset by player sales later in the window, there is no question about that.
I think the only other way around it is through direct capital injections by ENIC but I'm not sure if that is allowed as a covenant side-step. @PowerSpurs might know.
I think you are right about sales later in the window. They have to be ones that make an accounting profit though
The obvious sources of that are Romero, Sarr, Spence, Van de Ven, plus possibly Richarlison and Vicario.
Selling Romero for £65m and Sarr for £25 million would make a £75m profit I think so would allow about £250m of additional purchases. (£50m of amortisation plus an extra £25m of wages).
Last edited: